Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma.
Maartje M W LuijtenWillem Jan van WeeldenRoy I LalisangJohan BultenKristina LindemannHeleen van BeekhuizenHans TrumDorry BollHenrica M J WernerLuc R C W van LonkhuijzenRefika YigitCamilla KrakstadPetronella O WitteveenKhadra GalaalAlexandra A van GinkelEliana BignottiVit WeinbergerSanne SweegersAne Gerda Z ErikssonDiederick M KeizerAnja van de StolpeAndrea RomanoJohanna M A Pijnenborgnull European Network For Individualized Treatment In Endometrial CancerPublished in: Cancers (2024)
A trend towards lower PR-IHC and ERPAS was observed in lymphogenic sites. Verification in larger cohorts is needed to confirm these findings, which may have implications for the use of hormonal therapy in the future.